Rehmann Capital Advisory Group’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $690K | Sell |
9,871
-1,419
| -13% | -$99.2K | 0.04% | 288 |
|
|
2025
Q1 | $830K | Buy |
11,290
+570
| +5% | +$41.9K | 0.05% | 253 |
|
|
2024
Q4 | $702K | Buy |
10,720
+693
| +7% | +$45.4K | 0.04% | 269 |
|
|
2024
Q3 | $788K | Buy |
10,027
+175
| +2% | +$13.8K | 0.05% | 249 |
|
|
2024
Q2 | $768K | Buy |
9,852
+1,594
| +19% | +$124K | 0.06% | 247 |
|
|
2024
Q1 | $560K | Buy |
8,258
+547
| +7% | +$37.1K | 0.04% | 297 |
|
|
2023
Q4 | $519K | Buy |
7,711
+2,489
| +48% | +$168K | 0.04% | 308 |
|
|
2023
Q3 | $354K | Sell |
5,222
-53
| -1% | -$3.59K | 0.03% | 365 |
|
|
2023
Q2 | $378K | Sell |
5,275
-255
| -5% | -$18.3K | 0.03% | 367 |
|
|
2023
Q1 | $384K | Buy |
5,530
+239
| +5% | +$16.6K | 0.04% | 359 |
|
|
2022
Q4 | $359K | Buy |
5,291
+42
| +0.8% | +$2.85K | 0.04% | 365 |
|
|
2022
Q3 | $288K | Buy |
5,249
+600
| +13% | +$32.9K | 0.03% | 391 |
|
|
2022
Q2 | $307K | Buy |
4,649
+852
| +22% | +$56.3K | 0.03% | 368 |
|
|
2022
Q1 | $252K | Sell |
3,797
-843
| -18% | -$55.9K | 0.02% | 445 |
|
|
2021
Q4 | $270K | Sell |
4,640
-303
| -6% | -$17.7K | 0.03% | 460 |
|
|
2021
Q3 | $297K | Buy |
+4,943
| New | +$297K | 0.03% | 440 |
|
|
2020
Q4 | – | Sell |
-4,455
| Closed | -$244K | – | 483 |
|
|
2020
Q3 | $244K | Buy |
4,455
+247
| +6% | +$13.5K | 0.03% | 364 |
|
|
2020
Q2 | $223K | Buy |
+4,208
| New | +$223K | 0.03% | 381 |
|
|
2019
Q3 | $150K | Buy |
3,374
+321
| +11% | +$14.3K | 0.02% | 365 |
|
|
2019
Q2 | $126K | Sell |
3,053
-85
| -3% | -$3.51K | 0.02% | 546 |
|
|
2019
Q1 | $127K | Buy |
3,138
+245
| +8% | +$9.91K | 0.02% | 526 |
|
|
2018
Q4 | $110K | Buy |
2,893
+336
| +13% | +$12.8K | 0.02% | 386 |
|
|
2018
Q3 | $101K | Hold |
2,557
| – | – | 0.01% | 585 |
|
|
2018
Q2 | $89.8K | Sell |
2,557
-547
| -18% | -$19.2K | 0.01% | 585 |
|
|
2018
Q1 | $109K | Buy |
+3,104
| New | +$109K | 0.02% | 520 |
|